Abstract:Background: Inclusion bodies (IBs) are protein aggregates in recombinant bacterial cells containing mainly the target recombinant protein. Although it has been shown that IBs contain functional proteins along with protein aggregates, their direct application as pharmaceuticals is hindered by their heterogeneity and hazardous contaminants with bacterial origin. Therefore, together with the production of soluble species, IBs remain the main source for manufacture of recombinant proteins with medical application. The quality and composition of the IBs affect the refolding yield and further purification of the recombinant protein. The knowledge whether nucleic acids are genuine components or concomitant impurities of the IBs is a prerequisite for the understanding of the IBs formation and for development of optimized protocols for recombinant protein refolding and purification. IBs isolated from Escherichia coli overexpressing human interferon-gamma (hIFNγ), a protein with therapeutic application, were used as a model. Results: IBs were isolated from E. coli LE392 cells transformed with a hIFNγ expressing plasmid under standard conditions and further purified by centrifugation on a sucrose cushion, followed by several steps of sonication and washings with non-denaturing concentrations of urea. The efficiency of the purification was estimated by SDS-PAGE gel electrophoresis and parallel microbiological testing for the presence of residual intact bacteria. Phenol/chloroform extraction showed that the highly purified IBs contain both DNA and RNA. The latter were studied by UV spectroscopy and agarose gel electrophoresis combined with enzymatic treatment and hybridization. DNA was observed as a diffuse fraction mainly in the range of 250 to 1000 bp. RNA isolated by TRIzol® also demonstrated a substantial molecular heterogeneity. Hybridization with 32P-labelled oligonucleotides showed that the IBs contain rRNA and are enriched of hIFNγ mRNA. Conclusions: The results presented in this study indicate that the nucleic acids might be intrinsic components rather than co-precipitated impurities in the IBs. We assume that the nucleic acids are active participants in the aggregation of recombinant proteins and formation of the IBs that originate from the transcription and translation machinery of the microbial cell factory. Further studies are needed to ascertain this notion.

Comparative Purification and Characterization of Two HIN Domains, Hematopoietic Interferon-Inducible Nuclear Antigens with a 200-Amino-acid Repeat, in Murine AIM2-Like Receptors

Bacterial Expression of the HINab Domain of IFI16: Purification, Characterization of DNA Binding Activity, and Co-Crystallization with Viral Dsdna

Structural mechanism of DNA recognition by the p202 HINa domain: insights into the inhibition of Aim2-mediated inflammatory signalling.

Crystallographic Characterization of Mouse AIM2 HIN-200 Domain Bound to a 15 Bp and an 18 Bp Double-Stranded DNA.

Purification, characterization and docking studies of the HIN domain of human myeloid nuclear differentiation antigen (MNDA)

Structural mechanism of DNA recognition by the p204 HIN domain

A Novel Gene of Β Chain of the IFN-γ Receptor Ofhuiyangchicken: Cloning, Distribution, and CD Assay

Structures of the Hin Domain: Dna Complexes Reveal Ligand Binding and Activation Mechanisms of the Aim2 Inflammasome and Ifi16 Receptor

Characterization of a Strong Repression Domain in the Hinge Region of Orphan Nuclear Receptor Hb1f/hlrh-1.

Structural Mechanism of Dsdna Recognition by the Hmnda HIN Domain: New Insights into the DNA-binding Model of a PYHIN Protein.

Inhibition of AIM2 Inflammasome Activation by a Novel Transcript Isoform of IFI16.

Interaction Regions of N-Myc Interactor (nmi) and Interferon-Induced Protein 35 (ifp35) and Subcellular Localization of Nmi

Nucleic acids in inclusion bodies obtained from E. coli cells expressing human interferon-gamma

Prokaryotic Expression and Biologic Characteristics of Recombinant Human Interferon Α2a Protein in Intein-Mediated System

Molecular mechanisms of Innate DNA recognition by the AIM2 and IFI16 inflammasomes

Topology of receptor binding domains of mouse IFN-gamma.

Structural Insight into Hnrnp A2/B1 Homodimerization and DNA Recognition.

Molecular Mechanisms of Innate DNA Recognition by the AIM2 and IFI16 Inflammasomes (68.4)

An extracellular humanized IFNAR immunocompetent mouse model for analyses of human interferon alpha and subtypes

Identification, expression, and purification of a unique stable domain from human HSPC144 protein.

DNA Sensing by Innate Immune Receptors (INM6P.408)